Lenvatinib (AiViva BioPharma)

N/A

Report date: 2026/04/30 20:00:20

Base Information

Drug NameLenvatinib (AiViva BioPharma)
Drug Alias NameAIV-007
ClassificationBiologics
Mechanisms of ActionVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsDiabetic macular oedemaMacular EdemaMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAiviva Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAiviva Biopharma Inc
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedemaMacular EdemaMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A